Authors:
Brito, RA
Valero, V
Buzdar, AU
Booser, DJ
Ames, F
Strom, E
Ross, M
Theriault, RL
Frye, D
Kau, SW
Asmar, L
McNeese, M
Singletary, SE
Hortobagyi, GN
Citation: Ra. Brito et al., Long-term results of combined-modality therapy for locally advanced breastcancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience, J CL ONCOL, 19(3), 2001, pp. 628-633
Authors:
Berry, W
Dakhil, S
Gregurich, MA
Asmar, L
Citation: W. Berry et al., Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate, SEMIN ONCOL, 28(4), 2001, pp. 8-15
Authors:
Ibrahim, NK
Buzdar, AU
Asmar, L
Theriault, RL
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients:The M.D. Anderson experience, with long-term follow-up, ANN ONCOL, 11(12), 2000, pp. 1597-1601
Authors:
Chang, S
Alderfer, JR
Asmar, L
Buzdar, AU
Citation: S. Chang et al., Inflammatory breast cancer survival: The role of obesity and menopausal status at diagnosis, BREAST CANC, 64(2), 2000, pp. 157-163
Authors:
Hoff, PM
Valero, V
Buzdar, AU
Singletary, SE
Theriault, RL
Booser, D
Asmar, L
Frye, D
McNeese, MD
Hortobagyi, GN
Citation: Pm. Hoff et al., Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy, CANCER, 88(9), 2000, pp. 2054-2060
Citation: X. Pivot et al., The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review), INT J ONCOL, 15(2), 1999, pp. 381-386
Authors:
Holmes, FA
Valero, V
Walters, RS
Theriault, RL
Booser, DJ
Gibbs, H
Fraschini, G
Buzdar, AU
Willey, J
Frye, D
Asmar, L
Hortobagyi, GN
Citation: Fa. Holmes et al., Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results, ANN ONCOL, 10(4), 1999, pp. 403-411
Authors:
Vassilopoulou-Sellin, R
Asmar, L
Hortobagyi, GN
Klein, MJ
McNeese, M
Singletary, SE
Theriault, RL
Citation: R. Vassilopoulou-sellin et al., Estrogen replacement therapy after localized breast cancer: Clinical outcome of 319 women followed prospectively, J CL ONCOL, 17(5), 1999, pp. 1482-1487
Authors:
Buzdar, AU
Singletary, SE
Theriault, RL
Booser, DJ
Valero, V
Ibrahim, N
Smith, TL
Asmar, L
Frye, D
Manuel, N
Kau, SW
McNeese, M
Strom, E
Hunt, K
Ames, F
Hortobagyi, GN
Citation: Au. Buzdar et al., Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer, J CL ONCOL, 17(11), 1999, pp. 3412-3417
Authors:
Ibrahim, NK
Hortobagyi, GN
Ewer, M
Ali, MK
Asmar, L
Theriault, RL
Fraschini, G
Frye, DK
Buzdar, AU
Citation: Nk. Ibrahim et al., Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience, CANC CHEMOT, 43(6), 1999, pp. 471-478
Authors:
Pusztai, L
Asmar, L
Smith, TL
Hortobagyi, GN
Citation: L. Pusztai et al., Relapse after complete response to anthracycline-based combination chemotherapy in metastatic breast cancer, BREAST CANC, 55(1), 1999, pp. 1-8
Authors:
Raney, RB
Asmar, L
Vassilopoulou-Sellin, R
Klein, MJ
Donaldson, SS
Green, J
Heyn, R
Wharam, M
Glicksman, AS
Gehan, EA
Anderson, J
Maurer, HM
Citation: Rb. Raney et al., Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the intergroup rhabdomyosarcoma studies (IRS)-II and -III, MED PED ONC, 33(4), 1999, pp. 362-371
Authors:
Rahman, ZU
Frye, DK
Smith, TL
Asmar, L
Theriault, RL
Buzdar, AU
Hortobagyi, GN
Citation: Zu. Rahman et al., Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy - Areference, CANCER, 85(1), 1999, pp. 104-111